Skip to main content

Table 3 Baseline, procedural characteristics and 30-day outcomes of patients with percutaneous decannulation

From: Complete percutaneous angio-guided approach using preclosing for venoarterial extracorporeal membrane oxygenation implantation and explantation in patients with refractory cardiogenic shock or cardiac arrest

Percutaneous decannulation

n = 20

Patient's characteristics

 Age (years)

60 (27–76)

 Cardiac arrest (n)

11

  Ressuscitated cardiac arrest

10

  Refractory cardiac arrest

1

 STEMI (n)

13

 LVEF (%)a

15 (5–45)

 SOFA score

8 (3–14)

 ECMO duration (days)

6 (2–16)

Decannulation procedure

 Cross-over (n)

17

 Technical success (n)

19

 Need of covered stent implantation for hemostasis (n)

0 (0)

 Fluoroscopy time (min)

6.5 (2.1–19.6)

 Iodinated contrast volume (mL)

25 (10–140)

 Dose area product (cGy/cm2)

1236 (249–4277)

 Cumulated air karma (mGy)

140 (23–423)

Outcomes

 30-day mortality (n) (%)

11 (55%)

 ICU stay (days)

21 (5–47)

 Significant vascular complications (n)

1

  Need for surgical closure (n)

1

  Acute lower limb ischemia (n)

0

  Significant bleeding (n)

0

 Groin infection (n)

0

  1. Continuous data presented as median (min–max)
  2. STEMI ST-elevation myocardial infarction, LVEF left ventricle ejection fraction, ECMO extracorporeal membrane oxygenation, ICU intensive care unit
  3. aIn patients with spontaneous circulation